SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53

被引:15
|
作者
Chen, Fengjuan [1 ,2 ]
Zhang, Ka [3 ]
Huang, Yilin [4 ]
Luo, Fang [1 ]
Hu, Kunpeng [5 ]
Cai, Qingxian [1 ]
机构
[1] Third Peoples Hosp Shenzhen, Dept Hepatol, 29 Bulan Rd, Shenzhen 518112, Peoples R China
[2] Guangzhou Eighth Peoples Hosp, Dept Hepatol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Dept Rehabil, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Gen Surg, Affiliated Hosp 3, Guangzhou 510000, Peoples R China
来源
FEBS OPEN BIO | 2020年 / 10卷 / 07期
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; metastasis; p53; proliferation; SPC25; WGCNA; LIVER-DISEASE; CANCER; LOOP;
D O I
10.1002/2211-5463.12872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis and high mortality. To identify key genes associated with HCC and the underlying mechanisms, we performed weighted correlation network analysis (WGCNA) of potential key genes of HCC. We identified 17 key genes closely related to HCC by yellow module combined with PPI analysis. Verification of the role of these genes revealed that SPC25 knockdown results in a significant decrease in proliferation and metastasis of HCC cells and increased protein levels of components of the p53 pathway in vitro. In summary, we identified that SPC25 is a potential tumor-promoting factor in HCC and may act via the p53 pathway.
引用
收藏
页码:1261 / 1275
页数:15
相关论文
共 50 条
  • [21] Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma
    Jing, Zhao
    Nan, Ke-Jun
    Hu, Mei-Long
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (13) : 1910 - 1916
  • [22] P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
    Lee, Yu Rim
    Park, Soo Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (03) : 230 - 231
  • [24] BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer
    Mo, Qingfan
    Xu, Ke
    Luo, Chenghao
    Zhang, Qia
    Wang, Long
    Ren, Guosheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 553 : 17 - 24
  • [25] CDCA3 Promote Pancreatic Cancer Proliferation and Metastasis by Inhibited P53 Signal Pathway
    Guo, S.
    Wang, H.
    PANCREAS, 2019, 48 (10) : 1435 - 1436
  • [26] Highly Expressed SPC25 Promotes the Stemness, Proliferation and EMT of Oral Squamous Cell Carcinoma Cells via Modulating the TGF-β Signaling Pathway
    Zhang, Qiufang
    Zeng, Zijun
    Xie, Wen
    Zeng, Zhimei
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (03) : 195 - 204
  • [27] MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53
    Chen, Li
    Luo, Liang
    Chen, Wei
    Xu, Hong-Xu
    Chen, Fan
    Chen, Lian-zhou
    Zeng, Wen-Tao
    Chen, Jing-song
    Huang, Xiao-Hui
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1113 - 1118
  • [28] Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
    Wang, Zheng
    Jiang, Yuhui
    Guan, Dongxian
    Li, Jingjing
    Yin, Hongkun
    Pan, Yi
    Xie, Dong
    Chen, Yan
    PLOS ONE, 2013, 8 (09):
  • [29] Proliferation rate, hormone receptor status and p53 expression in skeletal metastasis of breast carcinoma
    Wedin, R
    Skoog, L
    Bauer, HCF
    ACTA ONCOLOGICA, 2004, 43 (05) : 460 - 466
  • [30] Telomerase expression and p53 status in hepatocellular carcinoma
    Kobayashi, T
    Sugawara, Y
    Shi, YZ
    Makuuchi, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (12): : 3166 - 3171